Under construction – not a live service

Skip to content

Frontlight Research

Trial site

CIUSSS de l Estrie - CHUS - Centre Hosp. Univ. Sherbrooke (Site 0003)

Sherbrooke, Quebec J1H 5N4, CanadaNot linked to an institution yet

1closed trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Head and neck cancer

Closed trials

Completed
A Study of Pembrolizumab (MK-3475) Plus Carboplatin and Paclitaxel as First-line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (MK-3475-B10/KEYNOTE B10)
NCT04489888· Phase 4· Merck Sharp & Dohme LLC· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Under construction, not live – CIUSSS de l Estrie - CHUS - Centre Hosp. Univ. Sherbrooke (Site 0003): trial site – Frontlight Research